176 related articles for article (PubMed ID: 34802574)
1. Posttreatment Magnetic Resonance Imaging Surveillance of Head and Neck Cancers.
Zuchowski C; Kemme J; Aiken AH; Baugnon KL; Abdel Razek AAK; Wu X
Magn Reson Imaging Clin N Am; 2022 Feb; 30(1):109-120. PubMed ID: 34802574
[TBL] [Abstract][Full Text] [Related]
2. Posttreatment Head and Neck Cancer Imaging: Anatomic Considerations Based on Cancer Subsites.
Hiyama T; Miyasaka Y; Kuno H; Sekiya K; Sakashita S; Shinozaki T; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230099. PubMed ID: 38386602
[TBL] [Abstract][Full Text] [Related]
3. Imaging of the Posttreatment Head and Neck: Expected Findings and Potential Complications.
Brahmbhatt S; Overfield CJ; Rhyner PA; Bhatt AA
Radiol Imaging Cancer; 2024 Jan; 6(1):e230155. PubMed ID: 38276904
[TBL] [Abstract][Full Text] [Related]
4. Advanced CT and MR Imaging of the Posttreatment Head and Neck.
Lobo R; Turk S; Bapuraj JR; Srinivasan A
Neuroimaging Clin N Am; 2022 Feb; 32(1):133-144. PubMed ID: 34809834
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Patients with Head and Neck Cancer: From Staging to Surveillance.
Seeburg DP; Baer AH; Aygun N
Oral Maxillofac Surg Clin North Am; 2018 Nov; 30(4):421-433. PubMed ID: 30143307
[TBL] [Abstract][Full Text] [Related]
6. Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI.
Lee JY; Cheng KL; Lee JH; Choi YJ; Kim HW; Sung YS; Chung SR; Ryu KH; Chung MS; Kim SY; Lee SW; Baek JH
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1392-1401. PubMed ID: 31320461
[TBL] [Abstract][Full Text] [Related]
7. Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know.
Saito N; Nadgir RN; Nakahira M; Takahashi M; Uchino A; Kimura F; Truong MT; Sakai O
Radiographics; 2012; 32(5):1261-82; discussion 1282-4. PubMed ID: 22977017
[TBL] [Abstract][Full Text] [Related]
8. Best Practices: Application of NI-RADS for Posttreatment Surveillance Imaging of Head and Neck Cancer.
Strauss SB; Aiken AH; Lantos JE; Phillips CD
AJR Am J Roentgenol; 2021 Jun; 216(6):1438-1451. PubMed ID: 32876470
[TBL] [Abstract][Full Text] [Related]
9. Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi-institutional study.
Workman AD; Velasquez N; Khan NI; Borchard NA; Kuan EC; Palmer JN; Wang EW; Patel ZM; Adappa ND
Int Forum Allergy Rhinol; 2019 Jun; 9(6):688-694. PubMed ID: 30768764
[TBL] [Abstract][Full Text] [Related]
10. NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
Baugnon KL
Neuroimaging Clin N Am; 2022 Feb; 32(1):1-18. PubMed ID: 34809832
[TBL] [Abstract][Full Text] [Related]
11. Posttreatment surveillance for sinonasal malignancy.
Workman AD; Palmer JN; Adappa ND
Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):86-92. PubMed ID: 27846019
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging of Perineural Spread of Head and Neck Cancer.
Abdelaziz TT; Abdel Razek AAK
Magn Reson Imaging Clin N Am; 2022 Feb; 30(1):95-108. PubMed ID: 34802584
[TBL] [Abstract][Full Text] [Related]
13. Perineural spread of malignant melanoma of the head and neck: clinical and imaging features.
Chang PC; Fischbein NJ; McCalmont TH; Kashani-Sabet M; Zettersten EM; Liu AY; Weissman JL
AJNR Am J Neuroradiol; 2004 Jan; 25(1):5-11. PubMed ID: 14729519
[TBL] [Abstract][Full Text] [Related]
14. Value of Dynamic Contrast-Enhanced MRI to Detect Local Tumor Recurrence in Primary Head and Neck Cancer Patients.
Choi YJ; Lee JH; Sung YS; Yoon RG; Park JE; Nam SY; Baek JH
Medicine (Baltimore); 2016 May; 95(19):e3698. PubMed ID: 27175712
[TBL] [Abstract][Full Text] [Related]
15. Differentiating recurrent tumours from post-treatment changes in head and neck cancers: does diffusion-weighted MRI solve the eternal dilemma?
Vaid S; Chandorkar A; Atre A; Shah D; Vaid N
Clin Radiol; 2017 Jan; 72(1):74-83. PubMed ID: 27789026
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
17. ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.
Aiken AH; Rath TJ; Anzai Y; Branstetter BF; Hoang JK; Wiggins RH; Juliano AF; Glastonbury C; Phillips CD; Brown R; Hudgins PA
J Am Coll Radiol; 2018 Aug; 15(8):1097-1108. PubMed ID: 29983244
[TBL] [Abstract][Full Text] [Related]
18. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
19. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck.
Parker GD; Harnsberger HR
Radiographics; 1991 May; 11(3):383-99. PubMed ID: 1852933
[TBL] [Abstract][Full Text] [Related]
20. Imaging of Perineural Spread in Head and Neck Cancer.
Badger D; Aygun N
Radiol Clin North Am; 2017 Jan; 55(1):139-149. PubMed ID: 27890182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
